CD274 and non-small cell lung carcinoma: On the other hand, in the first-line setting in advanced NSCLC patients, the predictive value of PD-L1 expression diminishes when ICI are combined with chemotherapy, as the survival benefit with the combination over chemotherapy alone is seen, regardless of PD-L1 expression and histologic subtype [24,25,26].